Dr Robert Heggie

  • Research Fellow (Health Economics & Health Technology Assessment)

telephone: 01413303047
email: Robert.Heggie@glasgow.ac.uk

Clarice Pears Building, HEHTA, School of Health & Wellbeing, 90 Byres Road, G12 8TB

Import to contacts

Biography

Robert is a Research Fellow working in the health economics and health technology assessment (HEHTA) research group here at the University of Glasgow. He has over 10 years experience working in this field and has a PhD in health economics and HTA.

Robert joined the University in November 2014 as a trainee Research Assistant within HEHTA. He has an MSc in Economics from the University of Birmingham and an MA in Economics from the University of Glasgow. Prior to taking up this role as a Research Assistant, Robert worked as an assistant economist with Fife Council and the Scottish Government (Civil Service).

Research interests

Robert's work is mainly focused on the analysis of clinical trial and observational data, with a view to informing HTA decisions. This typically involves a range of techniques, including: 

Evidence synthesis: systematic review and meta-analysis.

Predictive modelling: regression and survival analysis.

Clinical pathway and disease progression modelling: conceptual and decision-analytic modelling and analysis of epidemiological data.

Robert has worked on a diverse range of topics and disease areas including: cardiovascular disease, oncology, diabetes and pre-term labour. He is also involved in reviewing new product applications for the Scottish Medicines Consortium (SMC).

The focus of Robert's PhD was on the implementation of health technologies and how, by considering implementation early within the HTA evaluation process, we can ensure that promising health technologies are effectively translated from research findings into routine clinical practice.

If you would like to discuss collaboration or project supervision, please feel free to contact Robert via e-mail.

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015
Number of items: 31.

2024

Heggie, R., Boyd, K. , Kamaruzaman, H. and Wu, O. (2024) What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? a scoping review. Health Research Policy and Systems, 22(1), 134. (doi: 10.1186/s12961-024-01220-9) (PMID:39350148)

Lai, T.-J., Heggie, R., Kamaruzaman, H.-F., Bouttell, J. and Boyd, K. (2024) Economic evaluation of robotic assisted surgery: methods, challenges and opportunities. Applied Health Economics and Health Policy, (doi: 10.1007/s40258-024-00920-1) (PMID:39333303) (Early Online Publication)

Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

2023

Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

2022

Xin, Y. , Gray, E., Robles-Zurita, J. A., Haghpanahan, H. , Heggie, R., Kohli-Lynch, C., Briggs, A. , McAllister, D. A. , Lawson, K. D. and Lewsey, J. (2022) From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R. Applied Health Economics and Health Policy, 20(2), pp. 149-158. (doi: 10.1007/s40258-021-00684-y) (PMID:34671930)

Bouttell, J. , Heggie, R., Oien, K. , Romaniuk, A., VanSteenhouse, H., von Delft, S. and Hawkins, N. (2022) Economic evaluation of genomic/genetic tests: a review and future directions. International Journal of Technology Assessment in Health Care, 38(1), e67. (doi: 10.1017/S0266462322000484)

2021

Stock, S. J. et al. (2021) A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Health Technology Assessment, 25(52), (doi: 10.3310/hta25520) (PMID:34498576)

Heggie, R., Boyd, K. and Wu, O. (2021) How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Research Policy and Systems, 19, 118. (doi: 10.1186/s12961-021-00766-2)

Heggie, R. et al. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016) (PMID:33992700)

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Stock, S. J. et al. (2021) Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis. PLoS Medicine, 18(7), e1003686. (doi: 10.1371/journal.pmed.1003686) (PMID:34228732)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

2020

Heggie, R., Chappell, F., Crawford, F., Martin, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G.P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data. Diabetic Medicine, 37(12), pp. 2116-2123. (doi: 10.1111/dme.14339) (PMID:32510602)

Crawford, F. et al. (2020) Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment, 24(62), (doi: 10.3310/hta24620)

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2020) Mechanical thrombectomy in patients with acute ischemic stroke: a cost-effectiveness and value of implementation analysis. International Journal of Stroke, 15(8), pp. 881-898. (doi: 10.1177/1747493019879656) (PMID:31564243)

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Crawford, F., Nicolson, D. J., Amanna, A. E., Martin, A., Gupta, S., Leese, G. P., Heggie, R., Chappell, F. M. and McIntosh, H. H. (2020) Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia, 63, pp. 49-64. (doi: 10.1007/s00125-019-05020-7) (PMID:31773194) (PMCID:PMC6890632)

Heggie, R., Boyd, K. , Horne, M., Bruijn, M., Stock, S. and on behalf of the QUIDS research team, . (2020) When should we admit for preterm labour? An economic evaluation of the QUIDS prognostic model. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Chappell, F., Crawford, F., Green, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G. P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK. An analysis of routinely collected data. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

2019

Bouttell, J. , Teoh, J., Chiu, P. K., Chan, K. S., Ng, C.-F., Heggie, R. and Hawkins, N. (2019) Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong. PLoS ONE, 14(4), e0215279. (doi: 10.1371/journal.pone.0215279) (PMID:30990840) (PMCID:PMC6467402)

Paul, L., Renfrew, L., Freeman, J., Murray, H., Weller, B., Mattison, P., McConnachie, A. , Heggie, R., Wu, O. and Coulter, E. H. (2019) Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clinical Rehabilitation, 33(3), pp. 473-484. (doi: 10.1177/0269215518817080) (PMID:30514108)

Heggie, R., Murdoch, H., McIntosh, E. , Cameron, C., Smith-Palmer, A. and Bouttell, J. (2019) Cost-impact study of rotavirus vaccination programme in Scotland. Human Vaccines and Immunotherapeutics, 15(6), pp. 1265-1271. (doi: 10.1080/21645515.2018.1543522) (PMID:30395774)

2017

Heggie, R., Boyd, K. , Stock, S. and Bruijn, M. (2017) How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A600. (doi: 10.1016/j.jval.2017.08.1143)

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. 3rd European Stroke Organisation Conference (ESOC), Prague, Czech Republic, 16-18 May 2017.

2015

Geue, C. , Wu, O. , Xin, Y. , Heggie, R., Hutchinson, S., Martin, N. K., Fenwick, E. and Goldberg, D. (2015) Cost-effectiveness of HBV and HCV screening strategies – a systematic review of existing modelling techniques. PLoS ONE, 10(12), e0145022. (doi: 10.1371/journal.pone.0145022) (PMID:26689908) (PMCID:PMC4686364)

This list was generated on Wed Nov 20 21:59:48 2024 GMT.
Number of items: 31.

Articles

Heggie, R., Boyd, K. , Kamaruzaman, H. and Wu, O. (2024) What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? a scoping review. Health Research Policy and Systems, 22(1), 134. (doi: 10.1186/s12961-024-01220-9) (PMID:39350148)

Lai, T.-J., Heggie, R., Kamaruzaman, H.-F., Bouttell, J. and Boyd, K. (2024) Economic evaluation of robotic assisted surgery: methods, challenges and opportunities. Applied Health Economics and Health Policy, (doi: 10.1007/s40258-024-00920-1) (PMID:39333303) (Early Online Publication)

Sidik, N. P. et al. (2024) Invasive endotyping in patients with angina and no obstructive coronary artery disease: a randomized controlled trial. Circulation, 149(1), pp. 7-23. (doi: 10.1161/CIRCULATIONAHA.123.064751) (PMID:37795617)

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

Bradley, C. P. et al. (2023) The coronary microvascular angina cardiovascular magnetic resonance imaging trial: rationale and design. American Heart Journal, 265, pp. 213-224. (doi: 10.1016/j.ahj.2023.08.067) (PMID:37657593)

Falkowski, A. et al. (2023) How least developed to lower-middle income countries use health technology assessment: a scoping review. Pathogens and Global Health, 117(2), pp. 104-119. (doi: 10.1080/20477724.2022.2106108) (PMID:35950264) (PMCID:PMC9970250)

Xin, Y. , Gray, E., Robles-Zurita, J. A., Haghpanahan, H. , Heggie, R., Kohli-Lynch, C., Briggs, A. , McAllister, D. A. , Lawson, K. D. and Lewsey, J. (2022) From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R. Applied Health Economics and Health Policy, 20(2), pp. 149-158. (doi: 10.1007/s40258-021-00684-y) (PMID:34671930)

Bouttell, J. , Heggie, R., Oien, K. , Romaniuk, A., VanSteenhouse, H., von Delft, S. and Hawkins, N. (2022) Economic evaluation of genomic/genetic tests: a review and future directions. International Journal of Technology Assessment in Health Care, 38(1), e67. (doi: 10.1017/S0266462322000484)

Stock, S. J. et al. (2021) A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Health Technology Assessment, 25(52), (doi: 10.3310/hta25520) (PMID:34498576)

Heggie, R., Boyd, K. and Wu, O. (2021) How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Research Policy and Systems, 19, 118. (doi: 10.1186/s12961-021-00766-2)

Heggie, R. et al. (2021) Stratified medicine using invasive coronary function testing in angina: a cost-effectiveness analysis of the British Heart Foundation CorMicA trial. International Journal of Cardiology, 337, pp. 44-51. (doi: 10.1016/j.ijcard.2021.05.016) (PMID:33992700)

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Stock, S. J. et al. (2021) Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis. PLoS Medicine, 18(7), e1003686. (doi: 10.1371/journal.pmed.1003686) (PMID:34228732)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Heggie, R., Chappell, F., Crawford, F., Martin, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G.P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data. Diabetic Medicine, 37(12), pp. 2116-2123. (doi: 10.1111/dme.14339) (PMID:32510602)

Crawford, F. et al. (2020) Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment, 24(62), (doi: 10.3310/hta24620)

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2020) Mechanical thrombectomy in patients with acute ischemic stroke: a cost-effectiveness and value of implementation analysis. International Journal of Stroke, 15(8), pp. 881-898. (doi: 10.1177/1747493019879656) (PMID:31564243)

Crawford, F., Nicolson, D. J., Amanna, A. E., Martin, A., Gupta, S., Leese, G. P., Heggie, R., Chappell, F. M. and McIntosh, H. H. (2020) Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia, 63, pp. 49-64. (doi: 10.1007/s00125-019-05020-7) (PMID:31773194) (PMCID:PMC6890632)

Bouttell, J. , Teoh, J., Chiu, P. K., Chan, K. S., Ng, C.-F., Heggie, R. and Hawkins, N. (2019) Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong. PLoS ONE, 14(4), e0215279. (doi: 10.1371/journal.pone.0215279) (PMID:30990840) (PMCID:PMC6467402)

Paul, L., Renfrew, L., Freeman, J., Murray, H., Weller, B., Mattison, P., McConnachie, A. , Heggie, R., Wu, O. and Coulter, E. H. (2019) Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clinical Rehabilitation, 33(3), pp. 473-484. (doi: 10.1177/0269215518817080) (PMID:30514108)

Heggie, R., Murdoch, H., McIntosh, E. , Cameron, C., Smith-Palmer, A. and Bouttell, J. (2019) Cost-impact study of rotavirus vaccination programme in Scotland. Human Vaccines and Immunotherapeutics, 15(6), pp. 1265-1271. (doi: 10.1080/21645515.2018.1543522) (PMID:30395774)

Geue, C. , Wu, O. , Xin, Y. , Heggie, R., Hutchinson, S., Martin, N. K., Fenwick, E. and Goldberg, D. (2015) Cost-effectiveness of HBV and HCV screening strategies – a systematic review of existing modelling techniques. PLoS ONE, 10(12), e0145022. (doi: 10.1371/journal.pone.0145022) (PMID:26689908) (PMCID:PMC4686364)

Book Sections

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

Research Reports or Papers

Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.

Conference or Workshop Item

Heggie, R., Boyd, K. , Horne, M., Bruijn, M., Stock, S. and on behalf of the QUIDS research team, . (2020) When should we admit for preterm labour? An economic evaluation of the QUIDS prognostic model. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Chappell, F., Crawford, F., Green, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G. P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK. An analysis of routinely collected data. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C. (2020) Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

Heggie, R., Boyd, K. , Stock, S. and Bruijn, M. (2017) How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A600. (doi: 10.1016/j.jval.2017.08.1143)

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.

Heggie, R., Wu, O. , White, P., Ford, G. A., Wardlaw, J., Brown, M. M., Clifton, A. and Muir, K. W. (2017) Mechanical Thrombectomy in Patients With Acute Ischemic Stroke: A Cost-Effectiveness and Value of Implementation Analysis. 3rd European Stroke Organisation Conference (ESOC), Prague, Czech Republic, 16-18 May 2017.

This list was generated on Wed Nov 20 21:59:48 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Angina after PCI: a systems approach to inform downstream strategies
    British Heart Foundation
    2024 - 2029
     
  • AF Screening to Prevent Ischaemic StRokE (The ASPIRE Study) - The Role of Blood, ECG and Genetic Biomarkers
    Stroke Association
    2023 - 2025
     

Supervision

  • Lai, Tzu Jung
    How can Health Technology Assessment (HTA) support the optimal use of high-cost devices? A case study of robotic-assisted surgery in Scotland

Teaching

Robert is involved in a range of teaching duties here within HEHTA, including contributing towards the development and teaching of the following courses on our MSc programme;

  • HTA in a Global Context
  • Statistical Methods for HTA and evidence-based medicine
  • Data Science
  • Introduction to Survival Analysis

He is also tutor on our annual CPD courses:

  • Decision Analytic Modelling for Economic Evaluation
  • Evidence Synthesis for Health Technology Assessment 

Robert also acts as supervisor for multiple MSc students.

Professional activities & recognition

Professional & learned societies

  • 2024 - 2029: Chartered statistician, Royal Statistical Society

Selected international presentations

  • 2017: ISPOR 20th Annual European Congress (Glasgow, UK)
  • 2017: 3rd European Stroke Organisation Conference (ESOC) (Prague, Czech Republic)
  • 2019: European Health Economics Association (EuHEA) (Porto, Portugal)
  • 2019: Health Economists' Study Group (HESG) (Norwich, UK)